Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News

Data from Spain yield new insights on a rare hemophilia
- Author:
- Sharon Worcester
Publish date: November 2, 2021
News
CAR T for ALL: Areas that need optimizing
- Author:
- Sharon Worcester
Publish date: October 20, 2021
News
On improving DLBCL outcomes, single-agent regimens fall short
- Author:
- Sharon Worcester
Publish date: October 20, 2021
News
‘Unprecedented’ 3-year sustained survival with lung cancer combo treatment
- Author:
- Sharon Worcester
Publish date: October 4, 2021
News

COVID boosters help protect blood cancer patients, but some still vulnerable
- Author:
- Sharon Worcester
Publish date: September 30, 2021
News
Response to preop immunotherapy predicts survival in early NSCLC
- Author:
- Sharon Worcester
Publish date: September 30, 2021
News
Studies confirm survival benefit with postchemoradiotherapy consolidation in NSCLC
- Author:
- Sharon Worcester
Publish date: September 29, 2021
News
Study supports chemotherapy with immunotherapy for some never-smokers with lung cancer
- Author:
- Sharon Worcester
Publish date: September 28, 2021
News
First-line bevacizumab-osimertinib disappoint in EGFR-mutant NSCLC
- Author:
- Sharon Worcester
Publish date: September 24, 2021
News
Most community-based oncologists skip biomarker testing
- Author:
- Sharon Worcester
Publish date: September 21, 2021
News
Breast density associated with increased invasive breast cancer risk after age 65
- Author:
- Sharon Worcester
Publish date: September 17, 2021
News
Combo treatment for NSCLC with brain metastases extends survival by two years for some
- Author:
- Sharon Worcester
Publish date: September 15, 2021
News
COVID vaccine response in patients with solid tumors
- Author:
- Sharon Worcester
Publish date: September 9, 2021
News
FDA approves neoadjuvant pembro for triple-negative breast cancer
- Author:
- Sharon Worcester
Publish date: August 4, 2021
News

FDA warns of higher death risk with Pepaxto in multiple myeloma
- Author:
- Sharon Worcester
Publish date: July 28, 2021
